Search alternatives:
point decrease » point increase (Expand Search)
de decrease » we decrease (Expand Search), _ decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a de » _ de (Expand Search), a d (Expand Search), i de (Expand Search)
point decrease » point increase (Expand Search)
de decrease » we decrease (Expand Search), _ decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a de » _ de (Expand Search), a d (Expand Search), i de (Expand Search)
-
16981
Quality assessment for risk of bias for studies.
Published 2023“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
-
16982
Effect of tirzepatide vs placebo on body weight.
Published 2023“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
-
16983
The results of safety in meta-analysis.
Published 2023“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
-
16984
Graphs of risk of bias for studies.
Published 2023“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
-
16985
General baseline of included studies.
Published 2023“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
-
16986
-
16987
IQGAP1 is a protein that plays a critical role in regulating the level of apoptosis in endothelial cells.
Published 2025“…<p>(A) The Annexin V–FITC/propidium iodide (PI) assay results indicate that Si-IQGAP1 can slightly decrease the apoptosis rate of normal cells, whereas knocking down IQGAP1 in PA-induced cells (PA + Si-IQGAP1) can significantly reduce the apoptosis rate. …”
-
16988
An old medicine as a new drug to prevent mitochondrial complex I from producing oxygen radicals
Published 2019“…<div><p>Findings</p><p>Here, we demonstrate that OP2113 (5-(4-Methoxyphenyl)-3H-1,2-dithiole-3-thione, CAS 532-11-6), synthesized and used as a drug since 1696, does not act as an unspecific antioxidant molecule (i.e., as a radical scavenger) but unexpectedly decreases mitochondrial reactive oxygen species (ROS/H<sub>2</sub>O<sub>2</sub>) production by acting as a specific inhibitor of ROS production at the I<sub>Q</sub> site of complex I of the mitochondrial respiratory chain. …”
-
16989
-
16990
-
16991
-
16992
-
16993
-
16994
-
16995
-
16996
-
16997
-
16998
Microstructure Evolution of the Mg-5.8 Zn-0.5 Zr-1.0 Yb Alloy During Homogenization
Published 2022“…After homogenization, most of the eutectic phases dissolve into the matrix, except for a small amount of Mg-Zn-Yb phase. The area fractions of residual secondary phase decrease from 5.54% in the as-cast alloy to 0.59% in the well-homogenized sample. …”
-
16999
-
17000